AbCellera (Nasdaq: ABCL) will announce its full year 2025 financial results on Tuesday, February 24, 2026, and hold an ...
IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, was named No. 1 in its category on the 2026 Fortune® World’s Most Admired ...
VANCOUVER, BC / ACCESS Newswire / January 22, 2026 / LIR Life Sciences Corp. (CSE:SKNY)(Frankfurt:N790, WKN: A41QA9) ("LIR" ...
SOLANA BEACH, CALIFORNIA / ACCESS Newswire / January 22, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a ...
Sibnayal® sales rose 36.6% to €3.01m2025 Royalties are estimated at €1m, double the amount for 2024End-markets estimated ...
Under the liquidity agreement entrusted by Adocia (Euronext Paris: FR0011184241 – ADOC) to Kepler Capital Markets, the ...
Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a class action lawsuit against BellRing ...
Next generation Illig thermoformer set to elevate operations and significantly increase production capacity for further global expansionIn a key strategic move designed to accommodate increased volume ...
Tickets are on sale for the 40th anniversary of the PM Awards! Book now and join us on Friday 20th March 2026 at the JW Marriott Grosvenor House. This year, as a thank you for being a PM Society ...
Lund, Sweden, 22 January 2026. Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA), today announced that the company has been awarded the prestigious 2025 SwedenBIO Award. The award was presented at ...
Company lands new contract as demand surges for space-enabled drug researchDENVER--(BUSINESS WIRE)--Voyager Technologies ...
Curant Rare today announced a strategic collaboration with Cencora, a global pharmaceutical solutions organization, that aims to provide pharmaceutical companies developing rare disease therapies with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback